相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Lipoprotein Subfractions in Patients with Acute Coronary Syndromes: Should We Reach Beyond LDL-C?
Peter P. Toth
CURRENT VASCULAR PHARMACOLOGY (2019)
Substantial and Sustained Improvements in Blood Pressure, Weight and Lipid Profiles from a Carbohydrate Restricted Diet: An Observational Study of Insulin Resistant Patients in Primary Care
David J. Unwin et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Sodium Glucose Cotransporter-2 Inhibition and Cardiorenal Protection
David Z. Cherney et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Effects of Intermittent Fasting on Health, Aging, and Disease
Rafael de Cabo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Model-Based Evaluation of Proximal Sodium Reabsorption Through SGLT2 in Health and Diabetes and the Effect of Inhibition With Canagliflozin
Jessica A. Brady et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study
Nasir H. Bhanpuri et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Effects of sodium glucose co-transporter 2 inhibitors on the kidney
Natalia de Albuquerque Rocha et al.
DIABETES & VASCULAR DISEASE RESEARCH (2018)
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
Michael E. J. Lean et al.
LANCET (2018)
Loss of Metabolic Flexibility in the Failing Heart
Qutuba G. Karwi et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
Ralph A. DeFronzo et al.
NATURE REVIEWS NEPHROLOGY (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Impact of intermittent fasting on health and disease processes
Mark P. Mattson et al.
AGEING RESEARCH REVIEWS (2017)
Renal Handling of Ketones in Response to Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes
Ele Ferrannini et al.
DIABETES CARE (2017)
The heart failure epidemic: a UK perspective
Martin R. Cowie
ECHO RESEARCH AND PRACTICE (2017)
Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer
K. J. Mather et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
Ele Ferrannini et al.
DIABETES (2016)
Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis
Sunder Mudaliar et al.
DIABETES CARE (2016)
SGLT2 Inhibitors and the Diabetic Kidney
Paola Fioretto et al.
DIABETES CARE (2016)
SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study
Muhammad Abdul-Ghani et al.
DIABETES CARE (2016)
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus
Panai Song et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition
Giulia Ferrannini et al.
DIABETES CARE (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation
Nobutaka Nakamura et al.
DIABETOLOGY & METABOLIC SYNDROME (2015)
Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure
Alessandra Dei Cas et al.
JACC-HEART FAILURE (2015)
Integrated Control of Na Transport along the Nephron
Lawrence G. Palmer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Functional Role of Glucose Metabolism, Osmotic Stress, and Sodium-Glucose Cotransporter Isoform-Mediated Transport on Na+/H+ Exchanger Isoform 3 Activity in the Renal Proximal Tubule
Thaissa Dantas Pessoa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Heart failure: preventing disease and death worldwide
Piotr Ponikowski et al.
ESC HEART FAILURE (2014)
Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease
Sam Cherian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Insulin promotes macrophage foam cell formation: potential implications in diabetes-related atherosclerosis
Young M. Park et al.
LABORATORY INVESTIGATION (2012)
Evidence for a Causal Role of Oxidative Stress in the Myocardial Complications of Insulin Resistance
Rebecca H. Ritchie
HEART LUNG AND CIRCULATION (2009)
Fuel selection in human skeletal muscle in insulin resistance - A reexamination
DE Kelley et al.
DIABETES (2000)
分享论文
